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ABSTRACT (150 words) 
Purpose of review: Multiple digital devices exist that provide feedback on the 
accuracy of patient inhaler technique. Our purpose is to describe the inhaler technique 
feedback provided by these devices, including specific technique steps measured, how 
feedback is displayed, target of feedback (patient, provider, researcher), and 
compatibility with inhaler type (metered-dose inhaler, diskus, other).  
Recent findings: We identified eight devices that provide feedback on inhaler 
technique. Only one device assessed all evidence-based technique steps. Most devices 
provide limited real-time feedback to patients, if any feedback at all. 
Summary: Technologies to assess inhaler technique are advancing and hold 
great potential for improving patient inhaler technique. Many devices are limited in their 
ability to detect all evidence-based technique steps and provide real-time user-friendly 
feedback to patients and providers. Usability tests with patients and providers could 
identify ways to improve these devices to improve their utility in clinical settings.   
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Introduction (4,000 words, 1 figure, 2 tables) 
Asthma is projected to affect 400 million people worldwide by 2025,1 and 
currently affects more than 25 million people in the U.S.2 The economic burden of 
asthma is substantial, having been estimated at $56 billion per year in direct and 
indirect costs.3 Individuals with poorly controlled asthma have greater medical 
expenditures, use health services more often, and report more negative impact on work 
life and psychological health than individuals with controlled asthma.4,5 
Asthma control can be improved and costly negative sequel can be prevented 
when patients take medications appropriately.6-8 Unfortunately, many asthma 
interventions that target medication use focus exclusively on medication adherence or 
give minimal attention to inhaler technique, also referred to as inhaler competence.9 
Because improper technique can compromise delivery of inhaled medications to the 
lungs,10 patients with incorrect technique are significantly more likely to have poorly 
controlled asthma and more emergency department visits.11-13 The potential for inhaler 
technique interventions to improve asthma outcomes is substantial given that up to 92% 
of children14-16 and 96% of adults 17,18 demonstrate significant deficiencies in inhaler 
technique.  
Due to a number of barriers, including time constraints, providers often do not 
educate patients about how to use inhalers correctly during office visits.14 New 
electronic devices could provide a more streamlined and standardized method to 
educate patients about how to use their asthma inhalers in clinical settings. Indeed, two 
review articles documented that several digital inhaler monitoring devices are available 
to assess inhaler technique.9{Lavorini, 2010 #1575} These reviews have documented 
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that digital devices can validly and reliably assess patient inhaler technique, especially 
as it relates to inhalation maneuvers. However, these reviews are either outdated 
(published in 2010) or lack details about the specific technique steps assessed by the 
devices and the manner in which technique feedback is presented to providers and 
patients. 
Our purpose was to update and enhance previous research to describe the 
nature of inhaler technique feedback provided by electronic devices, with a focus on 
factors that could influence the utility and uptake of these devices in clinical settings. We 
specifically focus on: a) the specific technique steps assessed by the device; b) how 
feedback is presented; c) target of feedback (patient, clinician, researcher), d) 
compatibility with inhaler type (metered-dose inhaler [MDI], diskus, other dry powder 
inhaler [DPI]); e) cost; and f) whether the device is FDA-approved.  
Methods 
A systematic review of the literature and patents was conducted in November 
2016 to identify electronic devices capable of assessing inhaler technique. Figure 1 
summarizes our review and selection process. 
Search strategy. We first used PubMed to identify articles that described digital 
inhaler-based devices. We used the same search terms as a recent review of digital 
inhaler-based health monitoring devices that was completed in August 2015.9 In order 
to identify any new devices that may have been reported in the literature since August 
2015, we searched articles that were published between August 2015 and November 
2016. The specific search terms used were:  
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(("electronic" OR "monitoring" OR "sensing") AND "inhaler") OR ("Nebulizer 
Chronolog" OR "MDI Chronolog" OR "Aerosol Actuation Counter" OR 
"Turbuhaler Inhalation Computer" OR "Doser" OR "Electronic Diskhaler" OR 
"SmartMist" OR "MDILog" OR "Diskus Adherence Logger" OR "Smart Inhaler 
Tracker" OR "SmartTrack" OR "SmartDisk" OR "SmartTurbo" OR "SmartFlow" 
OR "SmartMat" OR "Inhaler Compliance Assessment Device" OR "INCA" OR 
"Asthmapolis" OR "Propeller Health" OR "Chameleon" OR "SmartTouch" OR 
"MDI Acoustic Actuation Detector" OR "pMDI Datalogger" OR "Geckocap" OR 
"CareTRx" OR "Inspiromatic" OR "Sensohaler" OR "T-Haler") 
In addition to the PubMed review, we examined references of important full-text 
articles for potentially missed devices and included relevant devices that were described 
in the previous review articles{Lavorini, 2010 #1575}{Kikidis, 2016 #1470} that were not 
captured in our PubMed search. These search strategies yielded 539 articles. 
We also conducted a patent search in order to identify devices that have been 
developed or are currently in development to assess inhaler technique that may have 
not yet been published in the peer-reviewed literature. Patent searches were conducted 
using Thomson Innovation (http://info.thomsoninnovation.com), which includes multiple 
databases of patents and patent applications from the U.S., Europe, World Intellectual 
Property Organization (WIPO), China, and several other geographies. The Derwent 
World Patents Index (DWPI) is accessible within the Thomson Innovation tool, enabling 
searching of English language abstracts from expert human editorial staffers, with an 
indexing system and patent families that group inventions across geographic filings. 
Within these databases, we conducted a search of patent titles, abstracts, and claims of 
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patents and patent applications from January 1988 to December 2016 using the 
following query: 
 ((inhaler* OR inhalation) AND (asthma)) AND ((sensor* OR track* OR monitor* 
OR record* OR display* NEAR10 (use OR efficien* OR compliance)). 
NEAR10 means the search included abstracts in which the words “use,” 
“efficien*” or “compliance” were within 10 words of any of the other search criteria 
words. This search yielded 125 potentially relevant patents. 
Selection criteria. For the literature search, we first reviewed the titles of the 539 
articles for potential relevance. Articles (n=31) with titles that referenced: 1) inhaler 
adherence and/or technique; 2) using an asthma monitoring device or sensor; or 3) the 
name and/or application of an inhaler-based monitoring device that was identified in 
previous reviews were selected for abstract review (n=31). To reduce bias, three 
individuals (CR, AS, DC) met to review these 31 abstracts to determine which articles 
would be selected for further full-text review. Of these 31 articles, 12 described devices 
that were capable of assessing at least one patient inhaler technique step and were 
selected for full-text review.  
Patent search results were reviewed for relevancy by a research analyst (AS), 
who identified 125 potentially relevant patents. Using the same selection criteria as the 
literature review, the analyst reviewed the titles and abstracts for each patent and 
identified 18 patents for further full-text review by second reviewer (DC). During full-text 
review of the 18 patients, both reviewers came to a consensus on which patents to 
include for data abstracting (n=2).  
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Exclusion criteria. Devices identified during the literature search and patent 
review were excluded if: 1) the device exclusively assessed medication adherence; 2) 
the device was developed to alter the manner in which the drug was delivered rather 
than to assess technique; 3) the device did not assess at least one essential inhaler 
technique step as defined by the Aerosol Drug Management Improvement (ADMIT) 
Team (see data extraction and analysis for more information on essential steps).19 
Additionally, we excluded one patent result that duplicated a device that was identified 
during the literature search. 
Data extraction and analysis. We extracted the following information for each 
device: 1) name of device; 2) which inhaler technique steps the device assesses; 3) 
how inhaler technique feedback is displayed; 4) the target of inhaler technique feedback 
(patient, clinician, researcher); 5) device compatibility (metered dose inhaler [MDI], 
diskus, other); 6) cost of device; and 7) whether the device is FDA approved (yes/no). 
The specific steps assessed by each device was cross-checked against the list 
of essential technique steps for MDI and diskus as identified in a recent review of the 
inhaler technique literature by the Aerosol Drug Management Improvement Team 
(ADMIT). 19 According to ADMIT19, the five essential steps for a metered dose inhaler 
(MDI) include: 1) prepare the device [uncap, shake, and hold inhaler vertically], 2) 
breathe out completely, 3) place teeth and lips around mouthpiece and press canister 
once while inhaling slowly and deeply, 4) breathe in slowly and deeply, and 5) hold 
breath for 5-10 seconds. The essential steps for a diskus are:1) prepare the device 
[uncap, load the inhaler], 2) turn away from the inhaler and breathe out completely, 3) 
place teeth and lips around the mouthpiece to form a seal, 4) breathe in with one brisk, 
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deep inhalation, and 5) hold the breath for 5 to 10 seconds or as long as possible. In 
order to ensure that our results were as complete as possible, we supplemented 
missing information from the article and patent search using one or more of the 
following strategies: 1) contacting the corresponding author of the article and/or device 
manufacturer (if known); 2) searching for the devices name on Google; and 3) 
searching for videos about the device on YouTube. 
Results 
 Table 1 presents an overview of the 7 devices included in the review.  
Steps assessed. No devices were capable of assessing all essential technique 
steps for an MDI. One device (add INCA ref) assessed all five essential steps for a 
diskus. Devices most commonly assessed steps related to patients’ breathing patterns 
(i.e., timing, force, and length of inhalation and exhalation). Four devices (X%) had the 
ability to detect with an MDI inhaler was shaken. Table 1 presents information about the 
specific steps assessed by each device. 
How feedback displayed. Feedback on inhaler technique was most commonly 
provided in real-time in the form of colored green or red lights (3 devices, xx%). Two 
devices provided real-time feedback in the form of digital displays that incentivized 
correct technique. For example, the T-haler showed a green dot moving into a “correct” 
box when the patient’s inhalation was optimal. Two devices did not provide any real-
time feedback; data was recorded, downloaded, and viewable in a spreadsheet. 
Target of feedback. Three devices (x%) were targeted specifically to patients, 2 
(X%) to clinicians, and 1 (X%) to researchers. One device (INCA) could be used by 
clinicians, researchers, and patients, but patients would need someone to help them 
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interpret the meaning of the audiofile to understand how the soundwaves relate to 
technique steps. The AIM is targeted for clinicians, but the nature of its feedback 
suggests that it could also be readily understood by patients. The SmartMist provides 
feedback on technique that is interpretable by both clinicians and patients.  
Device compatibility. The majority of devices (6; 86%) were compatible with 
MDIs. Three devices (add ref for pMDI datalogger article cited by Kikidis and Smartmist 
ref) were compatible with MDIs and spacers. Fewer devices are compatible with DPIs. 
Specifically, three devices, the INCA (add INCA cites), AIM (add AIM website), and 
Mag-Flo (Mag-flow website) are designed for use with a diskus. The Mag-Flo is also 
compatible with turbuhalers. 
Cost. Cost information was only available for one device. The AIM costs $405.  
FDA approval. Four devices (XX%) had received FDA approval.  
Discussion 
 This review summarizes key aspects of devices that have been developed to 
assess patient inhaler technique. Although several devices are currently available to 
assess inhaler technique, many have limitations as it relates to providing feedback on 
all essential technique steps or displaying feedback to providers and patients in a user-
friendly format. Few devices are available to assess technique for DPIs, especially 
turbuhalers and newer devices like Ellipta. Despite limitations with existing devices, 
there is significant opportunity to use these devices in clinical settings to instruct 
patients on proper use of their inhalers. 
Currently, no device provides feedback on all essential inhaler technique steps 
for MDIs, and only one device provides feedback on all essential diskus steps. Although 
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the MDI-compatible devices do not address all essential steps, they do provide 
feedback on the steps that are most difficult to assess with the naked eye (i.e., timing, 
force, and length of inhalation and exhalation). Many of these devices also provide 
feedback on whether the patient shook their inhaler, which is a commonly missed 
step.{Sleath, 2011 #394}{Lavorini, 2010 #1575} For these reasons, when coupled with 
feedback from a provider that addresses steps that these devices cannot measure (e.g., 
uncapping the inhaler and holding the inhaler vertically), these devices can provide 
useful information about the patient’s technique.  
Feedback on inhaler technique is most commonly provided to patients in verbal 
format by their providers. Although provider feedback on technique is an effective 
teaching method, observational studies have documented that technique 
demonstrations occur in just 12% of office visits.14,20 Low rates of inhaler technique 
instruction persist despite national guidelines that recommend inhaler technique skills 
should be demonstrated at every patient visit.21 Perceived time constraints and the 
number of health topics that need to be addressed during a typical office visit could 
potentially limit providers’ ability to engage in inhaler technique instruction. Thus, 
devices that provide automated technique feedback to patients could potentially 
enhance the ability of providers to provide technique education at every patient visit by 
reducing the amount of time necessary to assess patient’s device technique. Repeated 
instruction is especially desirable given that deterioration in technique has been 
documented as early as one month after receiving technique education {Basheti, 2007 
#819;Kamps, 2000 #788;Carpenter, 2014 #1129}{Lavorini, 2010 #1575}. 
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In addition to providing technique feedback in a time-efficient manner, inhaler 
technique devices can also provide tailored feedback to providers and patients on the 
specific steps that patients perform incorrectly. A large body of research has shown that 
tailored messages are more likely to be remembered and are more successful in 
influencing health behavior change than generic messages.23-25 Specific to inhaler 
technique, one small pilot study found that videos that were tailored to patient 
demographic characteristics and the specific steps patients missed led to significant 
improvements in inhaler technique that were maintained at 1-month follow-
up.{Carpenter, 2016 #1429} According to Social Cognitive Theory, mastery experience 
(or doing something correctly) is the most effective way to foster self-efficacy.26,27 Thus, 
if patients are made aware of the specific inhaler steps that they perform incorrectly in 
real-time, they can immediately correct those errors, which could increase their 
confidence to use their inhalers correctly (e.g. inhaler self-efficacy) and ultimately lead 
to better inhaler technique.  
There is also potential for these devices to improve patient inhaler technique in 
the home environment. Although none of these devices were intended for use outside of 
the clinical setting, daily feedback on inhaler technique may help ensure patients are 
using their inhalers correctly, especially for patients who receive a new prescription for 
an inhaler. In order to be feasible for home use, devices must be portable, affordable, 
and provider feedback to the patient in user-friendly and understandable manner. Two 
of the devices described in this review used real-time feedback to incentivize correct 
inhaler use. This type of feedback may be especially helpful for helping new inhaler 
users master appropriate inhaler technique. 
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Based on our findings, we suggest X main areas for future directions for 
development and evaluation of inhaler technique assessment devices. The first is 
related to device development; the development of devices that are capable of 
assessing all essential steps for MDIs and non-diskus DPIs are warranted. Second, 
device developers should involve target users (i.e., patients, providers) in the design 
process to ensure that feedback provided by the device is easily interpretable. Devices 
that provide feedback that is difficult to understand could limit device adoption and lower 
users’ perceptions of the devices’ utility. Adam- can you add a usability standards 
sentence here. Third, comparative effectiveness trials which evaluate the effectiveness 
of these devices at improving inhaler technique should be conducted. Such trials could 
compare the effectiveness of: 1) devices compared to one another and 2) devices 
compared to provider instruction and multimedia instruction (e.g., videos). 
Limitations 
 Our review of articles and patents was completed in December 2016. It is 
possible that newer devices are now available on the market and that we did not 
capture all devices in our search of the literature and patents. It is also possible that 
some of these devices described in this article are no longer commercially available. We 
did not include devices for which the primary purpose is to assess a patient’s inspiratory 
flow rate or inspiratory capacity to identify the best dry powder inhaler for them, even 
though these devices have the capability to assess specific technique steps related to 
correct inhalation.{Lavorini, 2010 #1575} Detailed information regarding the specific 
technique steps assessed, target of feedback, and method for providing technique 
feedback was lacking for several of the devices. Although we attempted to contact 
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authors and/or manufacturers to obtain additional information, including information on 
cost, inadequate detail may have led us to inaccurately document specific aspects of 
the devices.  
Conclusions 
 Inhaler technique, or competence, remains a relatively neglected area of patient 
education even though poor technique is associated with negative patient outcomes.11-
13 Electronic devices can provide a time-efficient and reliable way for healthcare 
providers to assess patient inhaler technique. Existing devices can provide objective 
feedback about correct technique for steps that are difficult to assess with the naked 
eye; such as whether the patient inhaled forcefully enough or coordinated inhaler 
actuation with inhalation. Our review identifies several areas of opportunity to make 
inhaler technique devices useful in clinical care and home settings. Major areas for 
improvement include developing devices to assess technique for non-diskus DPI 
inhalers and improving the quality of technique feedback so it is quickly and easily 
interpretable by patients and providers. Future research should explore whether these 
devices can facilitate providers’ ability to conduct inhaler technique assessments during 
office visits. 
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TABLES 
Table 1: Key Aspects of Digital Devices Capable of Assessing Patient Inhaler Technique 
Device Name Steps Assessed How 
Feedback 
Displayed 
Target of 
Feedback 
Device 
Compatibility 
Cost FDA 
Approval 
Inhaler 
Compliance 
Assessment 
Device 
(INCA) 
 
Diskus 
1) prepares the 
device (uncaps and 
shakes) 
2) breathes out 
completely 
3-4) Inhales slowly 
and deeply 
5) holds breath for 
5-10 seconds  
 
As a digital 
audio 
recording file 
and in 
calendar 
format for 
day/time used 
 
 
Clinician 
 
Patient (if 
audiofile 
explained) 
 
Researcher 
 
 
Diskus 
 
MDI and 
Elipta (in 
development) 
TBD Yes 
pMDI 
datalogger  
1) Shaking of 
inhaler 
2-5) Records 
breathing pattern of 
patient while using 
inhaler (including 
inhalation and 
exhalation time, 
duration, and 
volume) 
*cannot assess 
uncapping, inhaler 
orientation, or 
quality of lip seal 
Information 
not displayed 
in real-time 
 
Information 
recorded and 
displayed in 
Excel file 
when 
downloaded 
Researcher MDI (with and 
without 
spacer) 
Not 
published 
AUTHOR: 
Device 
provided by 
Respironics 
for study and 
doesn’t 
know 
“suspect it is 
quite high” 
No 
Aerosol 
Inhalation 
Monitor (AIM)  
 
MDI 
3-5) Correct 
canister activation 
(too early or not at 
all), inhalation 
rates, inhalation 
times, breath hold 
times 
 
Diskus 
(add steps) 
 
Real-time 
feedback 
provided on 
device 
screen; 
indicator 
lights (green, 
yellow, red) 
provide 
feedback on 
whether steps 
performed 
correctly 
Clinician 
  
MDI (with and 
without 
spacer)  
 
Diskus 
$405.00 US Yes 
T-haler  1) Shaking of 
inhaler 
3-4) timing of 
actuation and 
inhalation flow rate 
(and whether 
patient inhaled 
forcefully enough) 
Interactive 
video game 
that uses a 
dot and grid 
to show 
patients when 
the inhaled 
properly 
Patient 
 
MDI 
  
Unknown Unknown 
Smartmist  
 
 
 
3-4) slow and 
steady inhalation 
 
Red or green 
light 
Patient 
 
Clinician 
MDI Unknown Yes 
MDI log 1) shaking of 
inhaler 
3-4) inhaling slowly 
and deeply (timing 
Not 
displayed; 
 
Downloaded 
and printed 
Clinician 
 
 
MDI Unknown yes 
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Table 1: Key Aspects of Digital Devices Capable of Assessing Patient Inhaler Technique 
Device Name Steps Assessed How 
Feedback 
Displayed 
Target of 
Feedback 
Device 
Compatibility 
Cost FDA 
Approval 
of inhalation to 
actuation) 
as list of 
events or 
series of 
graphs 
An Inhaler 
spacer 
devices 
comprised of 
a microphone 
to detect to 
detect 
inhalation 
pressure 
(Patent 
Application: 
US20150059
739A1) 
 
4) breath in slowly 
and deeply 
 
Incentive 
graphic to 
indicate 
successful 
inhalation 
Patient MDI (with or 
without 
spacer) 
Unknown Unknown 
Mag-Flo Inhalation flow rate- 
Courtney- can you 
map onto ADMIT 
steps? 
Green lights 
turn on when 
patient 
reaches 
minimum 
inspiratory 
flow and stay 
on during 
inhalation as 
long as 
patient 
doesn’t 
inhaler too 
fast or too 
slow 
Patient Diskus 
 
Other DPI 
Courtney 
check 
Courtney 
check 
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FIGURES 
Figure 1: Overview of Literature and Patent Review Process 
 
539 Articles and 125 Patents Identified from Initial 
Search 
(n= 664) 
31 articles and 18 patents identified for 
abstract review 
(n=49) 
12 articles and 18 patents 
identified for article/patent full 
text review 
(n=30) 
Excluded (n=615) because title did not reference at 
least one of the following:  
 inhaler adherence and/or inhaler technique 
 use of an asthma monitoring device or sensor  
 the name of a known digital inhaler technique 
assessment device 
 
Excluded (n=22) because: 
 the device was developed to alter the manner 
in which the drug was delivered rather than 
assess technique with existing inhalers 
 the article/patent did not specify which 
technique steps were assessed  
 the patent duplicated a device located via 
literature search 
 
7 articles and 1 
patent selected 
(n=9) 
Excluded (n= 19) because:  
 The device exclusively assessed medication 
adherence 
 Device did not measure at least one inhaler 
technique step 
 
